ClassID:

96741

C07K7/083 - CPC Classification

Classification description:

Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof; Linear peptides containing only normal peptide links having 12 to 20 amino acids Neurotensin

Recent Application in this class:
#1
20250345446
2025-11-13

BIFUNCTIONAL MOLECULES THAT SELECTIVELY INDUCE DEGRADATION OF EXTRACELLULAR TARGETS IN LYSOSOMES

#2
20250122239
2025-04-17

DUAL AGONIST GLP-1 AND NEUROTENSIN FUSION PEPTIDE

#3
20250109169
2025-04-03

PEPTIDE USEFUL FOR THE TRANSPORT OF MOLECULES THROUGH CELL BARRIERS

#4
20240391967
2024-11-28

METHODS AND USES FOR NDFIP1 FUSION POLYPEPTIDES IN TREATING NEURODEGENERATIVE DISEASES, BRAIN AND/OR TRAUMATIC AND NON-TRAUMATIC SPINAL CORD INJURIES, AND/OR OPTIC NEUROPATHIES

#5
20240318157
2024-09-26

Neurotensin Variants And Tagged Proteins Comprising Neurotensin Or Sortilin Propeptide

#6
20230338555
2023-10-26

CONJUGATED OLIGONUCLEOTIDES AND USES THEREOF

#7
20230033268
2023-02-02

CHIMERIC POLYPEPTIDES AND USES THEREOF

#8
20220056077
2022-02-24

DUAL AGONIST GLP-1 AND NEUROTENSIN FUSION PEPTIDE

#9
20200316233
2020-10-08

RADIOPHARMACEUTICALS AND METHODS OF USE THEREOF

#10
20200157151
2020-05-21

PEPTIDE COMPOUNDS, CONJUGATE COMPOUNDS AND USES THEREOF FOR TREATING INFLAMMATORY DISEASES

#11
20180362582
2018-12-20

Macrocyclic compounds and methods of preventing or treating pain

#12
20170020951
2017-01-26

Neuropeptide analogs, compositions, and methods for treating pain

#13
20160354480
2016-12-08

Activated neurotensin molecules and the uses thereof

#14
20160015838
2016-01-21

Vinylsulfone-based 18F-labeling compositions and methods and uses thereof

#15
20150307554
2015-10-29

NTS-POLYPLEX NANOPARTICLES SYSTEM FOR GENE THERAPY OF CANCER

#16
20140113872
2014-04-24

Agonists and antagonists of the urotensinergic system

#17
20130324467
2013-12-05

NEUROPEPTIDE ANALOGS, COMPOSITIONS, AND METHODS FOR TREATING PAIN

#18
20130280281
2013-10-24

SHORT AND D-AMINO ACID-CONTAINING POLYPEPTIDES FOR THERAPEUTIC CONJUGATES AND USES THEREOF

#19
20130217632
2013-08-22

Non-natural amino acids

#20
20130210740
2013-08-15

NEO-TRYPTOPHAN

#21
20120277158
2012-11-01

COMPOSITIONS AND METHODS FOR THE TRANSPORT OF THERAPEUTIC AGENTS

#22
20120238490
2012-09-20

Methods and compositions for the treatment of metabolic disorders

#23
20120207676
2012-08-16

Neurotensin analogues for radioisotope targeting to neurotensin receptor-positive tumors

#24
20120178904
2012-07-12

PEPTIDE ANALOGS THAT ARE POTENT AND SELECTIVE FOR HUMAN NEUROTENSIN RECEPTOR SUBTYPE 2

#25
20120108519
2012-05-03

NEO-TRYPTOPHAN

#26
20110319339
2011-12-29

NEUROTENSIN-DERIVED BRANCHED PEPTIDES AND USES THEREOF

#27
20110263507
2011-10-27

PEPTIDE ANALOGS THAT ARE POTENT AND SELECTIVE FOR HUMAN NEUROTENSIN RECEPTOR SUBTYPE 2

#28
20110183885
2011-07-28

NEO-TRYPTOPHAN

#29
20100256055
2010-10-07

Conjugates of neurotensin or neurotensin analogs and uses thereof

#30
20100173849
2010-07-08

NEO-TRYPTOPHAN

#31
20090062212
2009-03-05

Peptide analogs that are potent and selective for human neurotensin preceptor subtype 2

#32
20080234202
2008-09-25

Non-natural amino acids and neurotensin analogues

#33
20080139481
2008-06-12

Non-Natural Amino Acids

#34
20070238197
2007-10-11

Fluorescent ligands for GPCR arrays

#35
20070173458
2007-07-26

Neo-tryptophan

#36
20070077195
2007-04-05

N and/or N derivatized, metal and organic protected L-histidine for coupling to biomolecules for highly efficient labeling with [M(OH)(CO)] by coordination

#37
20060148101
2006-07-06

Fluorescent ligands for GPCR arrays

#38
20050272661
2005-12-08

Neo-tryptophan

#39
20050191240
2005-09-01

Labeled neurotensin derivatives

#40
20050119454
2005-06-02

Algorithmic design of peptides for binding and/or modulation of the functions of receptors and/or other proteins

#41
20050027457
2005-02-03

Algorithmic design of peptides for binding and/or modulation of the functions of receptors and/or other proteins

#42
20050009205
2005-01-13

Fluorescent ligands for GPCR arrays